We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Genetix Completes Acquisition of Applied Imaging Corporation

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Genetix Completes Acquisition of Applied Imaging Corporation"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Read time:

Genetix Group plc. the cell biology and health technology group, has announced that following approval by the stockholders of Applied Imaging Corporation it has completed the acquisition of AI for approximately $25.8m in cash (approximately £13.6m).

Commenting on the acquisition, Mark Reid, Chief Executive of Genetix said:

“Combining with Applied Imaging will increase Genetix’ strength in cell imaging and analysis allowing us to exploit the growth opportunities in both the drug discovery and clinical diagnostics markets. As we move to integrate the two businesses, our priority is to expand our product portfolio and improve the level of support for our wider customer base and ultimately increase shareholder value.”